novabay pharmaceuticals inc
(NBY:Consolidated issues listed on NYSE MKT LLC)
Paul E. Freiman Ph.D.
Independent Director, Member of Audit Committee and Member of Compensation Committee, NovaBay Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 72 board members in 6 different organizations across 8 different industries.|
See Board Relationships
Dr. Paul E. Freiman, Ph.D., has been the Co-Chief Executive Officer of Neurotrope Bioscience, Inc since July 16, 2014. Dr. Freiman is an independent pharmaceutical and biotechnology industry consultant. He has extensive pharmaceutical and biotechnology industry operating experience. He served as an Interim Co-Chief Executive Officer at Neurotrope, Inc., from July 16, 2014 to September 12, 2014. He served as a Partner of Burrill Brasil Investimentos based in Rio de Janiero. ...
5980 Horton StreetPhone: 510-899-8800
Emeryville, California 94608
Board Members Memberships*
Former Lead Independent Director, Chairman of Remuneration Committee and Member of Audit Committee
Former Independent Director, Chairman of Audit Committee, Chairman of Nominating & Governance Committee and Member of Compensation Committee
Former Chairman, Member of Compensation Committee and Member of Nominating & Governance Committee
Independent Director, Member of Audit Committee and Member of Compensation Committee
Former Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Corporate Governance Committee
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|